These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27075237)

  • 1. A Prospective, Randomized, Masked, Placebo-Controlled Multisite Clinical Study of Grapiprant, an EP4 Prostaglandin Receptor Antagonist (PRA), in Dogs with Osteoarthritis.
    Rausch-Derra L; Huebner M; Wofford J; Rhodes L
    J Vet Intern Med; 2016 May; 30(3):756-63. PubMed ID: 27075237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of grapiprant, a novel EP4 antagonist: receptor binding, efficacy in a rodent postoperative pain model, and a dose estimation for controlling pain in dogs.
    Nagahisa A; Okumura T
    J Vet Pharmacol Ther; 2017 Jun; 40(3):285-292. PubMed ID: 27597397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody.
    Michels GM; Honsberger NA; Walters RR; Kira S Tena J; Cleaver DM
    Vet Anaesth Analg; 2023 Sep; 50(5):446-458. PubMed ID: 37541934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of grapiprant and meloxicam for management of postoperative joint pain in dogs: A randomized, double-blinded, prospective clinical trial.
    Cassemiche A; Schoffit S; Manassero M; Kohlhauer M
    J Vet Intern Med; 2024; 38(4):2324-2332. PubMed ID: 38944675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grapiprant: A snapshot of the current knowledge.
    Sartini I; Giorgi M
    J Vet Pharmacol Ther; 2021 Sep; 44(5):679-688. PubMed ID: 34057218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical efficacy study targeting mPGES1 or EP4 in dogs with spontaneous osteoarthritis.
    Robertson-Plouch C; Stille JR; Liu P; Smith C; Brown D; Warner M; Hu L; Fisher MJ
    Sci Transl Med; 2019 Oct; 11(516):. PubMed ID: 31666405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis.
    Corral MJ; Moyaert H; Fernandes T; Escalada M; Kira S Tena J; Walters RR; Stegemann MR
    Vet Anaesth Analg; 2021 Nov; 48(6):943-955. PubMed ID: 34565678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs.
    de Salazar Alcalá AG; Gioda L; Dehman A; Beugnet F
    BMC Vet Res; 2019 Aug; 15(1):309. PubMed ID: 31464629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of force plate gait analysis and owner assessment of pain using the Canine Brief Pain Inventory in dogs with osteoarthritis.
    Brown DC; Boston RC; Farrar JT
    J Vet Intern Med; 2013; 27(1):22-30. PubMed ID: 23311715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis.
    Brown DC; Boston RC; Coyne JC; Farrar JT
    J Am Vet Med Assoc; 2008 Oct; 233(8):1278-83. PubMed ID: 19180716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and toxicokinetic profiles associated with daily oral administration of grapiprant, a selective antagonist of the prostaglandin E2 EP4 receptor, to cats.
    Rausch-Derra LC; Rhodes L
    Am J Vet Res; 2016 Jul; 77(7):688-92. PubMed ID: 27347820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the safety of long-term, daily oral administration of grapiprant, a novel drug for treatment of osteoarthritic pain and inflammation, in healthy dogs.
    Rausch-Derra LC; Huebner M; Rhodes L
    Am J Vet Res; 2015 Oct; 76(10):853-9. PubMed ID: 26413822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic comparison of oral tablet and suspension formulations of grapiprant, a novel therapeutic for the pain and inflammation of osteoarthritis in dogs.
    Rausch-Derra LC; Rhodes L; Freshwater L; Hawks R
    J Vet Pharmacol Ther; 2016 Dec; 39(6):566-571. PubMed ID: 27027634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis.
    Vijarnsorn M; Kwananocha I; Kashemsant N; Jarudecha T; Lekcharoensuk C; Beale B; Peirone B; Lascelles BDX
    BMC Vet Res; 2019 Oct; 15(1):349. PubMed ID: 31623621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of a single oral dose of grapiprant in juvenile pigs (Sus scrofa domestica).
    Kleine S; Hampton CE; Smith C; Bussieres G; Mulon PY; Seddighi R; Cox S; Smith J
    J Vet Pharmacol Ther; 2023 Sep; 46(5):269-275. PubMed ID: 37493273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Power of treatment success definitions when the Canine Brief Pain Inventory is used to evaluate carprofen treatment for the control of pain and inflammation in dogs with osteoarthritis.
    Brown DC; Bell M; Rhodes L
    Am J Vet Res; 2013 Dec; 74(12):1467-73. PubMed ID: 24274882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two inhibitors of E-type prostanoid receptor four and carprofen in dogs with experimentally induced acute synovitis.
    Budsberg SC; Kleine SA; Norton MM; Sandberg GS
    Am J Vet Res; 2019 Nov; 80(11):1001-1006. PubMed ID: 31644340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic/pharmacodynamic evaluation of grapiprant in a carrageenan-induced inflammatory pain model in the rabbit.
    De Vito V; Salvadori M; Poapolathep A; Owen H; Rychshanova R; Giorgi M
    J Vet Pharmacol Ther; 2017 Oct; 40(5):468-475. PubMed ID: 27925221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of an oral nutraceutical for the treatment of canine osteoarthritis. A double-blind, randomized, placebo-controlled prospective clinical trial.
    Scott RM; Evans R; Conzemius MG
    Vet Comp Orthop Traumatol; 2017 Sep; 30(5):318-323. PubMed ID: 28763523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amantadine in a multimodal analgesic regimen for alleviation of refractory osteoarthritis pain in dogs.
    Lascelles BD; Gaynor JS; Smith ES; Roe SC; Marcellin-Little DJ; Davidson G; Boland E; Carr J
    J Vet Intern Med; 2008; 22(1):53-9. PubMed ID: 18289289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.